Implantica announces onboarding of the world-leading La Paz University Hospital, Spain
VADUZ, Liechtenstein, Feb. 6, 2025, 02:58 GMT-05
IMPLANTICA-Hospital
Read full article →
Category
Healthcare
This category brings together content related to healthcare, medicine, clinical research, healthcare services, medical devices, therapies and the development of solutions for the sector. Sector classification by EMSF Lisboa.
St. Luke's Medical Center Achieves GHA Accreditation for Medical Travel Services
PALM BEACH GARDENS, Fla., Feb. 6, 2025, 20:00 GMT-05
GlobalHealthcareAcc
Read full article →
Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment
PERTH, Australia, Feb. 6, 2025, 16:00 GMT-05
BioPharma-Report
Read full article →
GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC
SAN ANTONIO, Feb. 5, 2025, 13:30 GMT-05
Frost-Sullivan
Read full article →
Avalere Health launches new commitment to make EVERY PATIENT POSSIBLE
WASHINGTON and LONDON, Feb. 5, 2025, 12:00 GMT-05
Avalere-Launch-Commit
Read full article →
Doceree launches the first-ever unified admanager, built exclusively for healthcare publishers
SHORT HILLS, N.J., Feb. 5, 2025, 11:00 GMT-05
Doceree-Launch
Read full article →
Peptide Synthesis Market to Hit USD 1.41 Billion by 2029 with 11.7% CAGR | MarketsandMarkets™.
DELRAY BEACH, Fla., Feb. 5, 2025, 10:30 GMT-05
MARKETSANDMARKETS
Read full article →
Hospital Filtration Market worth $3.19 billion by 2030- Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Feb. 5, 2025, 06:30 GMT-05
MARKETSANDMARKETS
Read full article →
Neurolief Appoints Dr. Owen Muir as Chief Medical Officer to Drive Innovation in Depression Treatment
TAMPA, Fla., Feb. 5, 2025, 06:00 GMT-05
Neurolief-Appoints
Read full article →
Liva Healthcare acquires Momenta, and secures funding from new and existing investors to drive growth
COPENHAGEN, Denmark and LONDON, Feb. 5, 2025, 03:30 GMT-05
Liva-Healthcare
Read full article →
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
MILAN, Feb. 5, 2025, 03:00 GMT-05
Newronika-IDE-FDA
Read full article →
Dawn Health and Novartis Launch Cora BC for Breast Cancer Support
COPENHAGEN, Denmark, Feb. 5, 2025, 02:15 GMT-05
Dawn-Health-Cora-BC
Read full article →
EyeYon Medical Expands into China with New Subsidiary
ZHUHAI, China, Feb. 5, 2025, 20:00 GMT-05
EyeYon-Expands-China
Read full article →
Global Peptide-Drug Conjugate Market to Show Enormous Growth at a CAGR of ~29% by 2032 | DelveInsight
LAS VEGAS, Feb. 4, 2025, 17:31 GMT-05
DelveInsight-Business
Read full article →
Patient Advocates from NCCN Guidelines Panels Share Their 'United by Unique' Stories for World Cancer Day
PLYMOUTH MEETING, Pa., Feb. 4, 2025, 08:03 GMT-05
NCCN-World-Cancer-Day
Read full article →
Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology
BOSTON and LAUSANNE, Switzerland, Feb. 4, 2025, 03:30 GMT-05
Alys-Pharmaceuticals
Read full article →
Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market
LONDON, Feb. 4, 2025, 03:00 GMT-05
ClarivatePlc
Read full article →
Implantica announces completion of first GI-focused RefluxStop™ educational meeting by a prestigious NHS Hospital in the UK
VADUZ, Liechtenstein, Feb. 4, 2025, 02:50 GMT-05
IMPLANTICA-meeting
Read full article →
NICE Recommends Cytisine (Cytisinicline) Within The Treatments "More Likely" To Help Smokers Quit in Newly Updated Guidance
LONDON, Feb. 4, 2025, 01:14 GMT-05
CONSILIENT-HEALTH
Read full article →
Competitive Intelligence in Breast Cancer: Tracking the Evolving HR+ HER2-ve Breast Cancer Landscape
LAS VEGAS, Feb. 3, 2025, 17:31 GMT-05
DelveInsight-Business
Read full article →